SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-15-001868
Filing Date
2015-03-20
Accepted
2015-03-20 17:05:17
Documents
9
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K blcm-10k_20141231.htm 10-K 3126487
2 EX-23.1 blcm-ex231_20141231169.htm EX-23.1 2434
3 EX-31.1 blcm-ex311_201412318.htm EX-31.1 8446
4 EX-31.2 blcm-ex312_201412319.htm EX-31.2 8430
5 EX-32.1 blcm-ex321_2014123110.htm EX-32.1 6057
6 EX-32.2 blcm-ex322_2014123111.htm EX-32.2 5594
7 GRAPHIC g201503202058280477530.jpg GRAPHIC 61503
8 GRAPHIC g201503202058279077529.jpg GRAPHIC 61656
9 GRAPHIC g201503202058370947531.jpg GRAPHIC 44849
  Complete submission text file 0001564590-15-001868.txt   3390572
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 850 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 850 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36783 | Film No.: 15716915
SIC: 2834 Pharmaceutical Preparations